Simultaneous Expression Analysis of Vitamin D Receptor, Calcium Sensing Receptor, Cyclin D1 1

[1]  A. Brożyna,et al.  Expression of vitamin D receptor decreases during progression of pigmented skin lesions. , 2011, Human pathology.

[2]  H. DeLuca,et al.  Mechanisms and functions of vitamin D. , 2009, Nutrition reviews.

[3]  A. Behera,et al.  Anaemia and marrow fibrosis in patients with primary hyperparathyroidism before and after curative parathyroidectomy , 2009, Clinical endocrinology.

[4]  R. Salgia,et al.  Vitamin D Receptor Expression in Normal, Premalignant, and Malignant Human Lung Tissue , 2008, Cancer Epidemiology Biomarkers & Prevention.

[5]  C. Larsson,et al.  Distinction in gene expression profiles demonstrated in parathyroid adenomas by high-density oligoarray technology. , 2005, European journal of endocrinology.

[6]  R. Kitazawa,et al.  Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas. , 2003, European journal of endocrinology.

[7]  G. Hendy,et al.  Human Calcium-sensing Receptor Gene , 2002, The Journal of Biological Chemistry.

[8]  John Calvin Reed,et al.  Apoptosis induction by 1alpha,25-dihydroxyvitamin D3 in prostate cancer. , 2002, Molecular cancer therapeutics.

[9]  Sudhaker Rao,et al.  Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis , 2000, Clinical endocrinology.

[10]  J. Rastad,et al.  Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. , 2000, The Journal of clinical endocrinology and metabolism.

[11]  T. Dwight,et al.  Alternative genetic pathways in parathyroid tumorigenesis. , 1999, The Journal of clinical endocrinology and metabolism.

[12]  M. Vasef,et al.  Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[13]  T. Tsuzuki,et al.  Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma. , 1999, Kidney international.

[14]  N. Palanisamy,et al.  Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas. , 1998, The Journal of clinical endocrinology and metabolism.

[15]  C. Larsson,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Tumor-Specific Decreased Expression of Calcium Sensing Receptor Messenger Ribonucleic Acid in Sporadic Primary Hyperparathyroidism* , 2022 .

[16]  A. Arnold,et al.  Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study. , 1996, The Journal of clinical endocrinology and metabolism.

[17]  E. Brown,et al.  Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. , 1996, The Journal of clinical endocrinology and metabolism.

[18]  R. Eddy,et al.  Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. , 1989, The Journal of clinical investigation.

[19]  E. Brown,et al.  Abnormal calcium-regulated PTH release in normal parathyroid tissue from patients with adenoma. , 1981, The American journal of medicine.

[20]  A. Behera,et al.  Characteristics of Primary Hyperparathyroidism in Adolescents , 2008, Journal of pediatric endocrinology & metabolism : JPEM.

[21]  S. Masoodi,et al.  Primary hyperparathyroidism in north India: a description of 52 cases , 2005, Annals of Saudi medicine.

[22]  J. Gogusev,et al.  Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. , 1997, Kidney international.